Contract
Exhibit 99.9
The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
In accordance with Rule 13d-1(k)(1) promulgated under the Securities and Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with each other on behalf of each of them of such a statement on Schedule 13D (and any amendments thereto) with respect to the Ordinary Shares and American Depositary Shares, each of which represents twenty Ordinary Shares, evidenced by American Depositary Receipts, beneficially owned by each of them, of Chemomab Therapeutics Ltd., a corporation incorporated under the laws of the State of Israel. This Joint Filing Agreement shall be included as an exhibit to such Schedule 13D.
[Signature Page Follows]
IN WITNESS WHEREOF, the undersigned hereby execute this Joint Filing Agreement as of the 15th day of April, 2021.
| ACCESS INDUSTRIES HOLDINGS LLC | /s/ Xxxxxxxxx Xxxxxx Xxxxxxxxx Xxxxxx | |
| ACCESS INDUSTRIES MANAGEMENT, LLC | /s/ Xxxxxxxxx Xxxxxx Xxxxxxxxx Xxxxxx | |
| ACCESS INDUSTRIES, LLC | /s/ Xxxxxxxxx Xxxxxx Xxxxxxxxx Xxxxxx | |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | /s/ Xxxx Xxxxx Xxxx Xxxxx
/s/ Xxxxx Xxxxx Xxxxx Xxxxx
* Xxx Xxxxxxxxx | |
| * | The undersigned, by signing his name hereto, executes this Joint Filing Agreement pursuant to the Limited Power of Attorney executed on behalf of Xx. Xxxxxxxxx and filed herewith. |
| By: | /s/ Xxxxxxxxx Xxxxxx | |
| Name: Xxxxxxxxx Xxxxxx | ||
| Attorney-in-Fact |
